[Form 4] UL Solutions Inc. Insider Trading Activity
Rhea-AI Filing Summary
Hooper Charles W, a director of UL Solutions Inc. (ULS), reported dividend-equivalent accruals tied to deferred restricted stock units on 09/08/2025. Two entries show accruals of dividend-equivalent rights that convert one-for-one into Class A common shares: an accrual of rights equal to 10 underlying shares (price $0) leaving 4,946 shares beneficially owned after the transaction, and an accrual equal to 5 underlying shares (price $0) leaving 2,797 shares beneficially owned after the transaction. The filing notes the first set of deferred RSUs vested on May 1, 2025 and will be settled in shares per the Non-Employee Director Deferred Compensation Plan; the second set vests on the earlier of May 20, 2026 or the next annual meeting and will likewise be settled in shares under the Plan. The Form 4 was signed by an attorney-in-fact on 09/10/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation accruals converted to dividend equivalent rights; one grant vested and is eligible for settlement.
The filing documents non-derivative accruals of dividend-equivalent rights on deferred restricted stock units held by a director. One tranche vested on May 1, 2025 and is eligible for settlement under the issuer's Non-Employee Director Deferred Compensation Plan; a second tranche remains unvested until May 20, 2026 or the next annual meeting. This is a standard disclosure under Section 16 reflecting compensation-related share accruals rather than open-market purchases or sales.
TL;DR: Transaction shows accrual and vesting of RSU-related dividend equivalents; no cash consideration was paid.
The reported transactions are accruals of dividend equivalents converting to Class A common stock at no cash price (listed as $0), increasing beneficial ownership to the reported totals of 4,946 and 2,797 shares respectively. The transaction codes and explanatory notes indicate these are internal compensation mechanics rather than market activity, so immediate market impact is likely minimal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Unit | 10 | $0.00 | -- |
| Grant/Award | Deferred Restricted Stock Unit | 5 | $0.00 | -- |
Footnotes (1)
- Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
